- Report
- January 2026
- 386 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 474 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 294 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 279 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 287 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 381 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 590 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 181 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 287 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 381 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 140 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 476 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 207 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 380 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 379 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 485 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more